STARD7, a protein key to mitochondrial function, is overactive in breast cancer. Blocking it disrupts metabolism, builds up SAM, and slows tumor growth—showing mitochondria rely on STARD7 to drive cancer cell division.
The brain adjusts our decisions through the striatum by modulating two types of dopaminergic neurons: D1 neurons promote risk-taking, while D2 neurons adapt choices to our temperament. A key advance to better understand disorders such as addictions.
NIPU foams, recyclable at low temperatures, have been developed using disulphide bonds and hydroplasticisation, allowing their reuse as high-performance, durable adhesives suitable for a wide range of materials.
Laure Bindels received the Galien Prize for her work, carried out in collaboration with Laure Elens, on the interaction between the gut microbiota and tacrolimus, an essential immunosuppressant following organ transplantation.
Jak2 V617F mutation drives rare blood cancers, via the TpoR receptor, but its role was unclear. A new mouse model without TpoR showed partial disease signs, revealing both TpoR-dependent and independent effects, opening new paths for treatment.
Comparing different simulation approaches applied to diamond and boron arsenide has enhanced the reliability and reproducibility of calculations in materials science.
In 2026, a Belgian quantum sensor will be sent to the ISS with astronaut Raphaël Liégeois to study the behaviour of molecules in microgravity. Ludovic Troian-Gautier's team will lead research on photosensitive materials.
Altering specific appetite-related neurons in mice rapidly changed the gut microbiota, even without food intake. This connection is absent in obese and diabetic mice, suggesting a role in their metabolic imbalance.
TGF-β1, produced locally by pulmonary endothelial cells, guides the maturation of monocytes into interstitial macrophages that are essential for maintaining lung homeostasis.
An innovative continuous flow platform secures antibiotic production from agricultural waste by automating the nitration of bio-based compounds while eliminating risks associated with explosive agents.
Santero Therapeutics, active in the research of innovative drugs targeting highly antimicrobial-resistant pathogens, announced a first in vivo result based on a new and promising mode of action.
Activation of the β3-adrenergic receptor protects the diseased heart. The mechanism, which involves the transcription factor NRF2, triggers a sustained metabolic and antioxidant reprogramming to reduce cardiac stress.
